Prosecution Insights
Last updated: April 19, 2026

Jazz Pharmaceuticals Ireland Limited

6 pending office actions

Portfolio Summary

6
Total Pending OAs
1
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18294129 METHOD OF TREATING POSTTRAUMATIC STRESS DISORDER BELL, SARA ELIZABETH 1625 Non-Final OA Jan 31, 2024
18571860 SULFONAMIDE OREXIN RECEPTOR AGONISTS AND USES THEREOF OH, TAYLOR V 1625 Non-Final OA Dec 19, 2023
18558245 OREXIN RECEPTOR AGONISTS AND USES THEREOF HABTE, KAHSAY 1624 Non-Final OA Oct 31, 2023
18353770 BIARYL ETHER UREA COMPOUNDS REDWOOD, CHRISTOPHER EVAN 1629 Non-Final OA Jul 17, 2023
17918692 DEFIBROTIDE TREATMENT FOR THE PREVENTION OF ORGAN REJECTION AND INJURY AZPURU, CARLOS A 1617 Final Rejection Oct 13, 2022
17860498 GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS SIMMONS, CHRIS E 1622 Non-Final OA Jul 08, 2022

Managing Jazz Pharmaceuticals Ireland Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month